SAI LIFE SCIENCES Financial Statement Analysis
|
||
|
The Revenues of SAI LIFE SCIENCES have increased by 15.66% YoY .
The Earnings Per Share (EPS) of SAI LIFE SCIENCES has increased by 101.96 % YoY. |
||
SAI LIFE SCIENCES Last 5 Annual Financial Results
[BOM: 544306|NSE : SAILIFE]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹1,695 Cr | ₹1,465 Cr | ₹1,217 Cr | ₹870 Cr | ₹7,599 Cr |
| Expenses | ₹1,287 Cr | ₹1,178 Cr | ₹1,048 Cr | ₹745 Cr | ₹5,926 Cr |
| Operating Profit (Excl OI) | ₹408 Cr | ₹287 Cr | ₹169 Cr | ₹125 Cr | ₹1,673 Cr |
| Other Income | ₹37 Cr | ₹29 Cr | ₹28 Cr | ₹28 Cr | ₹273 Cr |
| Interest | ₹78 Cr | ₹88 Cr | ₹81 Cr | ₹53 Cr | ₹331 Cr |
| Depreciation | ₹139 Cr | ₹119 Cr | ₹99 Cr | ₹90 Cr | ₹796 Cr |
| Profit Before Tax | ₹228 Cr | ₹109 Cr | ₹16 Cr | ₹9.70 Cr | ₹819 Cr |
| Profit After Tax | ₹170 Cr | ₹83 Cr | ₹9.99 Cr | ₹6.23 Cr | ₹611 Cr |
| Consolidated Net Profit | ₹170 Cr | ₹83 Cr | ₹9.99 Cr | ₹6.23 Cr | ₹611 Cr |
| Earnings Per Share (Rs) | ₹16.48 | ₹8.16 | ₹46.88 | ₹1.75 | ₹3.55 |
| PAT Margin (%) | 15.89 | 10.03 | 5.64 | 0.82 | 0.72 |
| ROE(%) | 15.16 | 11.02 | 8.99 | 1.14 | 0.72 |
| ROCE(%) | 20.97 | 15.53 | 12.03 | 6.06 | 4.02 |
| Total Debt/Equity(x) | 0.04 | 0.06 | 0.74 | 0.80 | 0.86 |
Key Financials |
||
| Market Cap | : | ₹ 33,085.2 Cr |
| Revenue (TTM) | : | ₹ 2,250.4 Cr |
| Net Profit(TTM) | : | ₹ 361.7 Cr |
| EPS (TTM) | : | ₹ 17.0 |
| P/E (TTM) | : | 91.5 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SAI LIFE SCIENCES | 4.7% | 1.1% | 71.2% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.8% | -2.1% | 4.8% |
| DIVIS LABORATORIES | 4.9% | 7.9% | 54.7% |
| TORRENT PHARMACEUTICALS | 1.6% | -2.7% | 28.1% |
| CIPLA | 2.4% | 3.4% | -12% |
| DR REDDYS LABORATORIES | 2.6% | 14.2% | 3.9% |
| MANKIND PHARMA | -0.3% | -2% | 2.9% |
| LUPIN | 2.1% | -0.8% | 3.9% |
| ZYDUS LIFESCIENCES | 5.7% | 8.2% | 23.8% |
SAI LIFE SCIENCES Revenues
[BOM: 544306|NSE : SAILIFE]
| Y-o-Y | 15.66 % |
| 5 Yr CAGR | -31.28 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,695 Cr | 15.66 | |
| Mar2025 | ₹1,465 Cr | 20.38 | |
| Mar2024 | ₹1,217 Cr | 39.97 | |
| Mar2023 | ₹870 Cr | -88.56 | |
| Mar2022 | ₹7,599 Cr | - | |
SAI LIFE SCIENCES Operating Profit
[BOM: 544306|NSE : SAILIFE]
| Y-o-Y | 42.04 % |
| 5 Yr CAGR | -29.74 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹408 Cr | 42.04 | |
| Mar2025 | ₹287 Cr | 70.01 | |
| Mar2024 | ₹169 Cr | 35.24 | |
| Mar2023 | ₹125 Cr | -92.54 | |
| Mar2022 | ₹1,673 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 22.81 % |
| 5 Yr CAGR | 2.25 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 24.07% | 22.81 | |
| Mar2025 | 19.6% | 41.21 | |
| Mar2024 | 13.88% | -3.34 | |
| Mar2023 | 14.36% | -34.79 | |
| Mar2022 | 22.02% | - | |
SAI LIFE SCIENCES Profit After Tax
[BOM: 544306|NSE : SAILIFE]
| Y-o-Y | 105.45 % |
| 5 Yr CAGR | -27.36 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹170 Cr | 105.45 | |
| Mar2025 | ₹83 Cr | 729.00 | |
| Mar2024 | ₹9.99 Cr | 60.44 | |
| Mar2023 | ₹6.23 Cr | -98.98 | |
| Mar2022 | ₹611 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 58.42 % |
| 5 Yr CAGR | 116.74 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 15.89 % | 58.42 | |
| Mar2025 | 10.03 % | 77.84 | |
| Mar2024 | 5.64 % | 587.80 | |
| Mar2023 | 0.82 % | 13.89 | |
| Mar2022 | 0.72 % | - | |
SAI LIFE SCIENCES Earnings Per Share (EPS)
[BOM: 544306|NSE : SAILIFE]
| Y-o-Y | 101.96 % |
| 5 Yr CAGR | 46.79 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹16 | 101.96 | |
| Mar2025 | ₹8.16 | -82.59 | |
| Mar2024 | ₹47 | 2,578.86 | |
| Mar2023 | ₹1.75 | -50.70 | |
| Mar2022 | ₹3.55 | - | |
SAI LIFE SCIENCES Return on Capital Employed (ROCE)
[BOM: 544306|NSE : SAILIFE]
| Y-o-Y | 35.03 % |
| 5 Yr CAGR | 51.13 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 20.97% | 35.03 | |
| Mar2025 | 15.53% | 29.09 | |
| Mar2024 | 12.03% | 98.51 | |
| Mar2023 | 6.06% | 50.75 | |
| Mar2022 | 4.02% | - | |
SAI LIFE SCIENCES Share Price vs Sensex
| Current Share Price | : | ₹1,557.0 |
| Current MarketCap | : | ₹ 33,085.2 Cr |
| Updated EOD on | : | Nov 03,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAI LIFE SCIENCES | 4.7% |
1.1% |
71.2% |
| SENSEX | 4.5% |
6.1% |
-9.3% |
SAI LIFE SCIENCES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE 500 | 3.5% | 1.9% | -5.9% |
| BSE HEALTHCARE | 3.4% | 1.1% | 12.7% |
| BSE 1000 | 3.3% | 1.3% | -5.3% |
| BSE SELECT IPO INDEX | 2.3% | -1.6% | -8.1% |
| BSE 500 MOMENTUM 50 | 2% | -1.6% | -0.5% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY500 HEALTHCARE INDEX | 4% | 2.2% | 12.6% |
| NIFTY MIDSMALL HEALTHCARE | 3.9% | 2% | 18.1% |
| NIFTY PHARMA | 3.6% | 3% | 22% |
| NIFTY 500 | 3.6% | 2% | -5.5% |
| NIFTY500 MULTICAP INDIA MANUFACTURING 50:30:20 | 3.5% | 0.5% | 1.2% |
You may also like the below Video Courses
FAQ about SAI LIFE SCIENCES Financials
How the annual revenues of SAI LIFE SCIENCES have changed ?
The Revenues of SAI LIFE SCIENCES have increased by 15.66% YoY .
How the Earnings per Share (EPS) of SAI LIFE SCIENCES have changed?
The Earnings Per Share (EPS) of SAI LIFE SCIENCES has increased by 101.96 % YoY .
Check out Intrinsic Value of Peers of SAI LIFE SCIENCES
Compare Stock Analytics of Peers of SAI LIFE SCIENCES
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
